MYPLIFA Trademark

Trademark Overview

On Thursday, October 18, 2018, a trademark application was filed for MYPLIFA with the United States Patent and Trademark Office. The USPTO has given the MYPLIFA trademark a serial number of 88160757. The federal status of this trademark filing is REGISTERED as of Tuesday, December 1, 2020. This trademark is owned by Orphazyme A/S. The MYPLIFA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations to treat Niemann-Pick Type C, Inclusion Body Myositis, Amyotrophic Lateral Sclerosis and Gaucher disease
myplifa

General Information

Serial Number88160757
Word MarkMYPLIFA
Filing DateThursday, October 18, 2018
Status700 - REGISTERED
Status DateTuesday, December 1, 2020
Registration Number6208355
Registration DateTuesday, December 1, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations to treat Niemann-Pick Type C, Inclusion Body Myositis, Amyotrophic Lateral Sclerosis and Gaucher disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZEVRA DENMARK A/S
Party Type32 - New Owner After Registration
Legal Entity Type65 - NOT AVAILABLE
AddressFrederiksberg 2000
DK
Party NameKEMPHARM DENMARK A/S
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCopenhagen N 2200
DK
Party NameOrphazyme A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCopenhagen 2200N
DK
Party NameOrphazyme A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCopenhagen 2200N
DK
Party NameOrphazyme A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen 2200N
DK

Trademark Events

Event DateEvent Description
Monday, October 22, 2018NEW APPLICATION ENTERED
Wednesday, October 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 28, 2019ASSIGNED TO EXAMINER
Tuesday, January 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, April 5, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, July 21, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 7, 2019SOU TEAS EXTENSION RECEIVED
Thursday, November 7, 2019SOU EXTENSION 1 FILED
Thursday, November 7, 2019SOU EXTENSION 1 GRANTED
Saturday, November 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 2, 2020TEAS PETITION TO AMEND BASIS RECEIVED
Monday, July 27, 2020ASSIGNED TO PETITION STAFF
Thursday, July 30, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, July 30, 2020ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, August 5, 2020NOTICE OF ALLOWANCE CANCELLED
Wednesday, August 5, 20201(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, August 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 15, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, May 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 5, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 7, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 7, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 5, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 1, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

myplifa pharmaceutical preparations amyotrophic lateral gaucher disease myositis sclerosis inclusion treat